Results per Page:
Assessing HER2 expression in metastatic prostate and urothelial cancers
From Dr. Raychaudhuri, Dr. Haffner and colleagues, Clinical Research Division
Dr. Yeon Soo Kim receives NIH Pathway to Independence Award
Hsieh Lab postdoctoral fellow studies how advanced prostate cancer evades therapy by altering the way RNA builds proteins
Inside every patient, a universe
From the Haffner Lab, Human Biology Division
Fred Hutch Cancer Center announces 2025 Evergreen Fund awardees
Nine Fred Hutch researchers receive funding totaling $1.175 million for projects with commercial partnership potential
Trazar la heterogeneidad de las células tumorales en el cáncer de próstata resistente a la castración
Del Laboratorio Haffner, Divisiones de Biología Humana e Investigación Clínica
Mapping tumor cell heterogeneity in castrate-resistant prostate cancer
From the Haffner Lab, Human Biology and Clinical Research Divisions
Mapping novel “beacons” for targeted therapy in prostate cancer
From the Haffner lab, Human Biology and Clinical Research Divisions
Interrogating heterogeneous PSMA expression in advanced prostate cancer
From the Haffner Lab, Human Biology Division
Identification of potential driver mutations in rare prostate cancer subtype
From the Haffner, Lee, and Ha Labs, Prostate Cancer and Biostatistics and Computational Biology Programs, Cancer Consortium.